Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Research at the Kennedy Institute reveals sub-populations of stromal cells with distinct functions in human fibrotic disease. These findings could inform development of more specific therapies with fewer off-target effects.

Dupuytren’s disease hand examination.
The study used human fibrotic tissue from Dupuytren’s disease, a common fibrotic condition of the hand

In their study, published in Nature Communications, the authors utilised single cell technologies to map different types of stromal cells and their relationship to each other in human tissues affected by fibrosis. Their approach revealed several distinct populations of stromal cells with different functional roles.

Fibrotic disorders arise from poorly regulated tissue repair processes, leading to a build-up of collagen and scar tissue that impairs organ function. These diseases are some of the most devastating and poorly treated conditions in the Western world, yet effective therapeutics are often lacking. 

Lead author Jagdeep Nanchahal said: "Animal models fail to replicate many aspects of human fibrosis and there remains limited availability of well-characterised patient samples at developing stages of disease. Our study exclusively used human fibrotic tissue from Dupuytren's disease, a common fibrotic condition of the hand, to profile an entire human fibrotic ecosystem at single cell resolution."


"We were able to build a single cell atlas of human fibrosis-promoting stromal cells and describe functionally distinct types and states. This division of labour between fibrotic stromal cells will allow us to form a powerful translational resource to help inform development of treatments and represents an exciting avenue for future research," he concluded.

Similar stories

Plaster cast or metal pins to treat a broken wrist? The results are in.

An Oxford study published in The BMJ has found the use of metal K-wires (commonly known as ‘pins’) to hold broken wrist bones in place while they heal are no better than a traditional moulded plaster cast.

Professor Chris Buckley has joined the Kennedy Institute as Director of Clinical Research

Moving to the University of Oxford with the Arthritis Therapy Acceleration Programme (A-TAP) will help accelerate the discovery of new treatments for inflammatory diseases.

Behind enemy lines: research finds a new ally in the fight against cardiovascular disease hidden within the vessel wall itself

A new study reveals the existence of a powerful ally in the fight against cardiovascular disease, a protective subset of vascular macrophages expressing the C-type lectin receptor CLEC4A2, a molecule which fosters “good” macrophage behaviour within the vessel wall.

More effective treatment found for patients hospitalised with COVID-19 pneumonia

A proof-of-concept trial involving Oxford researchers has identified a drug that may benefit some patients hospitalised with COVID-19 pneumonia.

NDORMS researchers honoured in the Recognition Of Distinction Scheme 2021

Sally Hopewell and John Christianson have been awarded the title of ‘Full Professor’ in the University of Oxford’s Recognition Of Distinction Scheme 2021.

New Oxford-Zeiss Centre of Excellence opens at the University of Oxford

The Kennedy Institute for Rheumatology and the Institute of Developmental and Regenerative Medicine announce the launch of the Oxford-Zeiss Centre of Excellence, providing state-of-the-art imaging technologies to lead future discoveries in global health and disease.